Latest News about psychedelics
Recent news which mentions psychedelics
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
From Benzinga
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment
February 29, 2024
Tickers
CMPS
From Benzinga
Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
February 29, 2024
From Benzinga
Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights
February 29, 2024
From Benzinga
EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds
February 29, 2024
From Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
From Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
February 28, 2024
From Benzinga
What's Going On With Incannex Stock?
February 28, 2024
From Benzinga
Cannabis Industry Veteran On Market Trends, DEA Rescheduling, THC Types, Psychedelics And More
February 28, 2024
Tickers
THC
From Benzinga
Biotech Company Develops Inebriation Remedy Beverage 'UNBUZZD'
February 26, 2024
From Benzinga
Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments
February 23, 2024
From Benzinga
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
February 21, 2024
From Benzinga
From Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.